Immunological Medicine
Volume 42, 2019 - Issue 4
Open access
1,832
Views
14
CrossRef citations to date
0
Altmetric
Original Article
Prognostic value of IL-34 in colorectal cancer patients
Takuto KobayashiDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
, Muhammad BaghdadiDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
, Nanumi HanDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
, Tomoki MurataDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
, Naoki HamaDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
, Ryo OtsukaDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
, Haruka WadaDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; View further author information
, Manabu ShiozawaDepartment of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan; View further author information
, Tomoyuki YokoseDepartment of Pathology, Kanagawa Cancer Center, Yokohama, Japan; View further author information
, Yohei MiyagiMolecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan; View further author information
, Atsushi TakanoDepartment of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Japan; ;Center for Advanced Medicine against Cancer, Shiga University of Medical Science, Otsu, Japan; ;Center for Antibody and Vaccine Therapy, Research Hospital, Institute of Medical Science, the University of Tokyo, Tokyo, JapanView further author information
, Yataro DaigoDepartment of Medical Oncology and Cancer Center, Shiga University of Medical Science, Otsu, Japan; ;Center for Advanced Medicine against Cancer, Shiga University of Medical Science, Otsu, Japan; ;Center for Antibody and Vaccine Therapy, Research Hospital, Institute of Medical Science, the University of Tokyo, Tokyo, JapanView further author information
& Ken-Ichiro SeinoDivision of Immunobiology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan; Correspondence[email protected]
View further author information
show allView further author information
Pages 169-175
|
Received 14 Jun 2019, Accepted 03 Nov 2019, Published online: 23 Nov 2019
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.